Coherence Neuro raises $45M Series A from Founders Fund and OpenAI Startup Fund to build cancer therapy that learns
iskander · x · 2026-10-22
Neurotech startup Coherence Neuro announced a $45M Series A co-led by Founders Fund and the OpenAI Startup Fund to build "cancer therapy that learns."
- Founder Ben Woodington argues cancer care lacks data loops: patients learn far too slowly whether treatment is working
- The company is building neurotechnology/BCI platforms to watch cancer in real time and feed that data into a system that continuously improves itself
- The cofounders appeared on the owl posting podcast (episode #9, 2+ hours) covering why cancer cells act like neurons, BCIs for glioblastoma, and pan-cancer neuromodulation
More from Venture
- belo ships agentic banking for LATAM via MCP with human approval on every transaction — yenkel · 2026-10-22
- Anduril CEO: US capital markets are 'thousands of times better,' financing $200B of data centers — a16z · 2026-10-22
- Ares Founder: Prediction Markets Don't Have a Liquidity Problem, They Have a Discovery Problem — morganlai · 2026-10-22
- General Catalyst co-led Serval's seed round, betting on agentic IT workflows — marcbhargava · 2026-10-22
- ARK analyst: marginal robotaxi rides could destabilize Uber driver network — skorusARK · 2026-10-22
- Podium rebuilds to $150M AI ARR in 2.5 years — eight times faster than the first time — ycombinator · 2026-10-22